The initial public offering (IPO) of Amanta Healthcare
1) Amanta Healthcare raised Rs 37.8 crore from six institutional investors via anchor book on August 29. The company, in its filing to exchanges, said it has finalised allocation of 30 lakh shares to anchor investors at Rs 126 per share. Out of the total allocation of 30 lakh shares, 7.93 lakh shares were allocated to Bandhan Mutual Fund which applied through its Small Cap Fund.
2) Amanta Healthcare, which seeks valuation of nearly Rs 500 crore, intends to spend Rs 70 crore of IPO proceeds for setting up new manufacturing line of SteriPort, and Rs 30.13 crore for new manufacturing line for small volume parenteral (SVP) at Hariyala, Gujarat. The remainder funds will be set aside for general corporate purposes.
3) The IPO will remain open for public bidding from September 1 to September 3. The allotments will likely be finalized by September 4, and the shares are scheduled to debut on BSE and NSE on September 8
4) ROCE @13.72% & rOE at 12.42%
5) PE pre ipo - 34.59 - Debt equity @ 2.02 times
6) Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment. stock on radar -